Browsing Tag
ONP-002
3 posts
Why neuroinflammation and systemic inflammation are becoming central targets in traumatic brain injury research
Why are neuroinflammation and systemic inflammation becoming major targets in traumatic brain injury research? Explore the industry shift now.
How intranasal neurosteroids may change emergency care timing in mild traumatic brain injury
Can ONP-002 change concussion care timing? Discover how Oragenics, Inc. is targeting early intervention in mTBI treatment.
The $9bn concussion treatment question Oragenics hopes ONP-002 can answer
Oragenics launches Phase IIa trial of ONP-002 for concussion. Discover whether this therapy could unlock the $9B traumatic brain injury market.